Dupilumab Cuts Itch and Hives in Chronic Spontaneous Urticaria: Phase 3 CUPID Trials
USA: Dupilumab significantly reduced itch and hive severity in patients with chronic spontaneous urticaria (CSU) who remained symptomatic despite antihistamine therapy, findings from the phase 3 LIBERTY-CSU CUPID trials published…